Collegium Pharmaceutical, Inc (COLL)

Last Three Months

31-Dec-22 -- 30-Mar-23

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Drugs - Generic

Drugs

Insider Trading Sentiment: Reduce

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

20

0

5

+1

0

+2

0

+3

Two Year Chart

31-Mar-21 -- 30-Mar-23

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
14-Feb-23 5:18 PM View:	13-Feb-23 Sale (Planned) ($586.28K)	Kuhlmann Shirley R. EVP and General Counsel		Collegium Pharmaceutical, Inc - COLL	26% 109.5K to 137.5K	0	0	--	--	Show Txns Hide Txns

14-Feb-23 5:16 PM View:	13-Feb-23 Planned Option Sale ($302.40K)	Ciaffoni Joseph President and CEO Director		Collegium Pharmaceutical, Inc - COLL	61% 248.75K to 400.09K	0	0	--	--	Show Txns Hide Txns

03-Mar-23 4:08 PM View:	01-Mar-23 Private Sale (Planned) ($355.75K)	Dreyer Scott EVP & Chief Commercial Officer		Collegium Pharmaceutical, Inc - COLL	12% 120.63K to 134.88K	0	0	--	--	Show Txns Hide Txns

17-Mar-23 4:11 PM View:	15-Mar-23 Private Sale (Planned) ($752.16K)	Tupper Colleen EVP & Chief Financial Officer		Collegium Pharmaceutical, Inc - COLL	17% 90.3K to 105.42K	0	0	--	--	Show Txns Hide Txns

14-Feb-23 5:19 PM View:	10-Feb-23 Grant 0	Smith Thomas B EVP and Chief Medical Officer		Collegium Pharmaceutical, Inc - COLL	100% 0 to 31.18K	0	0	--	--	Show Txns Hide Txns